GET THE APP
Myelogenous Leukemia | Open Access Journals
..

Journal of Cytology & Histology

ISSN: 2157-7099

Open Access
Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Submit Manuscript arrow_forward arrow_forward ..

Myelogenous Leukemia

Ceaseless myelogenous leukemia (CML), otherwise called incessant myeloid leukemia, is a malignant growth of the white platelets. It is a type of leukemia portrayed by the expanded and unregulated development of myeloid cells in the bone marrow and the gathering of these phones in the blood. CML is a clonal bone marrow undifferentiated organism issue in which an expansion of develop granulocytes (neutrophils, eosinophils and basophils) and their antecedents is found. It is a sort of myeloproliferative neoplasm related with a trademark chromosomal translocation called the Philadelphia chromosome. CML is to a great extent rewarded with focused medications called tyrosine-kinase inhibitors (TKIs) which have prompted significantly improved long haul endurance rates since 2001. These medications have changed treatment of this malady and permit most patients to have a decent personal satisfaction when contrasted with the previous chemotherapy drugs. In Western nations, CML represents 15–25% of every single grown-up leukemia and 14% of leukemias by and large (counting the pediatric populace, where CML is less common).

High Impact List of Articles
Conference Proceedings

Relevant Topics in Genetics & Molecular Biology

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 2334

Journal of Cytology & Histology received 2334 citations as per Google Scholar report

Citation image
Journal of Cytology & Histology peer review process verified at publons
Publon image

Indexed In

Related Links

PMC/PubMed Indexed Articles
In Situ Hybridisation Study of Neuronal Neuropeptides Expression in Models of Mandibular Denervation with or without Inflammation: Injury Dependant Neuropeptide Plasticity
Loss of Expression of a Novel Chromatin Remodeler SMARCA1 in Soft Tissue Sarcoma

View More »

 

Open Access Journals

arrow_upward arrow_upward